S&E Bio Co., Ltd.
- Biotech or pharma, therapeutic R&D
S&E bio Co., Ltd. is a clinical-stage biotech venture company developing therapeutics based on stem cell-derived exosomes.
The lead asset is an acute ischemic stroke therapeutic, which has received approval for a Phase 1b clinical trial in Korea and is currently in preparation for clinical execution.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}